about
sameAs
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acidDevelopment and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaThe impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological responseFocal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?Treatment of hepatitis C: critical appraisal of the evidence.Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.Hyperferritinemia is a risk factor for steatosis in chronic liver disease.Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn's disease.Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report.Should cirrhosis change our attitude towards treating non-hepatic cancer?Causes of and prevention strategies for hepatocellular carcinoma.Assessment of treatment response in hepatocellular carcinoma: a review of the literature.Imaging appearance of treated hepatocellular carcinomaIs the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?Staging systems of hepatocellular carcinoma: a review of literature.Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis.Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.Computed tomography of bowel obstruction: tricks of the trade.Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.Recurrence of hepatocellular carcinoma after liver transplantation: an update.Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.Curative therapies for hepatocellular carcinoma: an update and perspectives.A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.The cheating liver: imaging of focal steatosis and fatty sparing.Second line systemic therapies for hepatocellular carcinoma: Reasons for the failureHepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma.Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension.Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib.Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.
P50
Q26769602-2AAD944E-7C97-4276-BD01-9710FD815CACQ28551586-AF6D8460-546A-4D09-9A37-0F79FE08A5AEQ31133052-1BF90056-554F-4178-A961-7DAD307329AAQ31133052-3F990A82-7E9E-466E-93FE-AC18AB9273AAQ34905429-2DB4ED1E-8410-4D4B-9BED-F3596A409BC2Q34905429-81C2F4D4-75DA-4E63-B714-66AFFA7B10D2Q35721144-422653C1-D84D-4A2E-B47D-22121F138428Q35721144-E01DFB4D-EF20-4828-9096-D2CA2026CA93Q36082056-29CA67ED-834E-466A-9A69-860408D5E003Q36082056-2E7D4FD8-09B2-4ECB-89BA-FE38C28118BEQ36876393-0BA5A80F-7592-41F5-892A-682FDFF1F1FBQ36876393-4C95ECAE-B4B4-4FA8-A60C-196CD2139833Q37182959-19A3F6CF-D406-4EA7-9018-9DACE0B938CDQ37182959-AEAA9CA6-47BF-43F0-9BBB-E58FBD292B6BQ37281815-DC225546-AE4C-4110-8A9F-B50B8E06AA3DQ37281815-E8399AC2-6F29-453B-B19E-EF7C3BB117E3Q37429037-848FA7A7-792F-4F3D-9C60-BB98A8C4296FQ37429037-9E0C97D8-8676-4937-8C74-E60B903AD332Q37958071-104EB0B1-CFAD-477F-9AA5-C26E2C429864Q37958071-42CBC0B5-67B6-476C-8E0A-996F53D8A6E9Q38030772-6419D4AA-E606-4633-96F5-528DD6C37674Q38030772-B80C674B-F844-4805-9404-7E99F4201EBEQ38110321-EB2ADBAC-7EBB-4F2A-BBA6-607DEB4D7E86Q38110321-F679D078-A9CC-4A8F-BAC9-B53DF78B523EQ38136207-25DA18CE-CD57-45EB-8E95-A38DF9EBC3E3Q38136207-A20EF515-986F-4036-A773-7A0CDCF6D0D2Q38162294-3978D5F8-B4FD-41FD-88A7-7550AEA62FABQ38162294-E1950724-6FEA-4A4A-89FE-A9B1290A15B5Q38207014-903F82E1-AD1D-44CE-B253-77EF456A20C6Q38207014-B95117AC-1B2F-4BC9-9991-DA93E54F083EQ38213650-BB3AFEAC-F898-4B7B-B79A-46491005D719Q38213650-CA6C45F6-4F7D-4404-951D-3D92560C9965Q38340168-3DC6101B-9293-431B-9A5E-1E271407DC6CQ38340168-B75BFC7F-C110-4CA9-9DB9-E184BEF8E63DQ38416518-928773B3-8978-4A7F-987F-A3C75E126AADQ38532499-84F3F316-2E08-463E-AC16-5EAB6BFA38E4Q38532499-A37278FA-04D1-42CA-84BC-42383A1E55A0Q38591681-362ABBD4-8E85-4D9E-812E-EB3A147F29E6Q38594469-68465739-D816-4A5A-AE89-D524E45EE75BQ38632730-14C93B61-F6E0-4B7C-A469-9DC8CD476378
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giuseppe Cabibbo
@ast
Giuseppe Cabibbo
@en
Giuseppe Cabibbo
@es
Giuseppe Cabibbo
@nl
Giuseppe Cabibbo
@sl
type
label
Giuseppe Cabibbo
@ast
Giuseppe Cabibbo
@en
Giuseppe Cabibbo
@es
Giuseppe Cabibbo
@nl
Giuseppe Cabibbo
@sl
prefLabel
Giuseppe Cabibbo
@ast
Giuseppe Cabibbo
@en
Giuseppe Cabibbo
@es
Giuseppe Cabibbo
@nl
Giuseppe Cabibbo
@sl
P106
P1153
22978623500
P21
P31
P496
0000-0002-0946-3859